<DOC>
<DOCNO>
EP-0007633
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
C07D-501/04 A61P-31/00 C07D-417/12 C07D-209/48 C07D-277/00 C07D-501/20 C07D-501/22 C07D-501/16 C07D-277/38 <main>C07D-501/22</main> C07D-417/00 A61K-31/545 A61K-31/546 A61P-31/04 C07D-501/59 C07D-277/20 C07D-501/00 C07D-209/00 C07D-277/40 
</IPC-CLASSIFICATIONS>
<TITLE>
cephem compounds, processes for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
fujisawa pharmaceutical cojp<sep>fujisawa pharmaceutical co. ltd.<sep>fujisawa pharmaceutical co., ltd.3, doshomachi 4-chome higashi-kuosaka-shi osaka 541jp<sep>fujisawa pharmaceutical co., ltd.<sep>
</APPLICANT>
<INVENTOR>
chiba toshiyuki<sep>takasugi hisashi<sep>takaya takao<sep>tsuji kiyoshi<sep>chiba, toshiyuki<sep>takasugi, hisashi<sep>takaya, takao<sep>tsuji, kiyoshi<sep>chiba, toshiyukino. 1-212, 2-5, nakamotohigashinari-ku, osakajp<sep>takasugi, hisashino. 2-12-7, kohamanishisuminoe-ku, osakajp<sep>takaya, takaono. 1-5-87, suimeidaikawanishijp<sep>tsuji, kiyoshino. 2-17-2, nagai-cho-nakasumiyoshi-ku, osakajp<sep>chiba, toshiyuki<sep>takasugi, hisashi<sep>takaya, takao<sep>tsuji, kiyoshi<sep>chiba, toshiyukino. 1-212, 2-5, nakamotohigashinari-ku, osakajp<sep>takasugi, hisashino. 2-12-7, kohamanishisuminoe-ku, osakajp<sep>takaya, takaono. 1-5-87, suimeidaikawanishijp<sep>tsuji, kiyoshino. 2-17-2, nagai-cho-nakasumiyoshi-ku, osakajp<sep>
</INVENTOR>
<ABSTRACT>
a compound of the formula:    wherein r¹ is amino or protected amino,   r² is lower alkyl substituted with a substituent  selected from the groups consisting of cyano,  carbamoyl, hydroxy, protected hydroxy, amino,  protected amino, lower alkoxy, lower alkylthio,  lower alkenylthio, aryl which may have one or  more suitable substituent(s), and heterocyclic  group which may have one or more suitable  substituent(s),   r³ is carboxy or functionally modified carboxy, and   r⁴ is hydrogen or halogen   and its pharmaceutically acceptable salt and pharmaceuti­ cally acceptable bioprecursor thereof and process for their  preparation.  the invention also relates to a pharmaceutical composi­ tion comprising, as an effective ingredient, the above com­ pound in association with a pharmaceutically acceptable,  substantially nontoxic carrier or excipient, and to a method for  treating an infectious disease caused by pathogenes, which  comprises administering the above compound to infected  human being or animals.  
</ABSTRACT>
</TEXT>
</DOC>
